MAKOTO Capital logo

MAKOTO Capital

Asia, Miyagi, Japan, Sendai

Description

MAKOTO Capital engages in VC business, venture studio business, and management consulting business.

Investor Profile

MAKOTO Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series B rounds (top funding stages).
  • Majority of deals are located in Japan.
  • Strong thematic focus on Industrial, Manufacturing, Biotechnology.

Stage Focus

  • Seed (50%)
  • Series B (50%)

Country Focus

  • Japan (100%)

Industry Focus

  • Industrial
  • Manufacturing
  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MAKOTO Capital frequently co-invest with?

Genesia Ventures
Asia, Kanagawa, Japan, Shibuya
Co-Investments: 1
LA
Asia, Yamanashi, Japan, Shinjuku
Co-Investments: 1
Dai-ichi Life
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
MIRAI SOUZOU
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Tohoku University Venture Partners
Asia, Miyagi, Japan, Sendai-shi
Co-Investments: 1
Seraphim Space
Europe, England, United Kingdom, London
Co-Investments: 1
Plug and Play Japan
North America, California, United States, Sunnyvale
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Alfresa Holdings
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by MAKOTO Capital?

ElevationSpace

Miyagi, Hokkaido, Japan

ElevationSpace is a space utilization and recovery platform.

IndustrialManufacturing
SeedMar 8, 2022
Amount Raised: $2,678,741
Metcela

Kawasaki, Kanagawa, Japan

Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.

BiotechnologyHealth CareMedical
Series BJan 4, 2021
Amount Raised: $12,700,000